Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CANCER TREATMENT DRUG
Document Type and Number:
WIPO Patent Application WO/2023/140355
Kind Code:
A1
Abstract:
[Problem] Provided is a cancer treatment drug that suppresses the proliferation of cancer cells. [Solution] This cancer treatment drug contains a compound represented by general formula (1) or a pharmaceutically acceptable salt thereof.

Inventors:
SATO MOTOHIKO (JP)
UMEZAWA KAZUO (JP)
YAMAMURA AYA (JP)
Application Number:
PCT/JP2023/001710
Publication Date:
July 27, 2023
Filing Date:
January 20, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AICHI MEDICAL UNIV (JP)
International Classes:
A61K31/427; A61P13/08; A61P35/00; A61P35/04; A61P43/00
Domestic Patent References:
WO2014150252A12014-09-25
Other References:
DAS DIBASH K.; NAIDOO MICHELLE; ILBOUDO ADEODAT; PARK JONG Y.; ALI THAHMINA; KRAMPIS KONSTANTINOS; ROBINSON BRIAN D.; OSBORNE JOSE: "miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin", EXPERIMENTAL CELL RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 348, no. 2, 29 September 2016 (2016-09-29), AMSTERDAM, NL , pages 190 - 200, XP029772450, ISSN: 0014-4827, DOI: 10.1016/j.yexcr.2016.09.021
SATO MOTOHIKO, HIRAOKA MASAHIRO, SUZUKI HIROKO, SAKIMA MIHO, MAMUN ABDULLAH AL, YAMANE YUKIKO, FUJITA TAKAYUKI, YOKOYAMA UTAKO, OK: "Protection of Cardiomyocytes from the Hypoxia-Mediated Injury by a Peptide Targeting the Activator of G-Protein Signaling 8", PLOS ONE, vol. 9, no. 3, pages e91980, XP093079469, DOI: 10.1371/journal.pone.0091980
DATABASE REGISTRY ANONYMOUS : "- 1-Naphthalenesulfonic acid, 2-[2-[1,5-dihydro-3-methyl-5-oxo-1-(4-phenyl-2- thiazolyl)-4H-pyrazol-4-ylidene]hydrazinyl]- (CA INDEX NAME)", XP093079406, retrieved from STN
Attorney, Agent or Firm:
MARUYAMA Osamu et al. (JP)
Download PDF:



 
Previous Patent: ELASTIC WAVE DEVICE AND FILTER DEVICE

Next Patent: DISPLAY DEVICE